{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:20:21Z","timestamp":1790911221729,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.preghy.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T13:09:23Z","timestamp":1518786563000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Thrombotic microangiopathies of pregnancy: Differential diagnosis"],"prefix":"10.1016","volume":"12","author":[{"given":"M.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.B.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Burwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2018.02.007_b0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2016.04.009","article-title":"Pregnancy-related thrombotic microangiopathies: Clues from complement biology","volume":"54","author":"Fakhouri","year":"2016","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.preghy.2018.02.007_b0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.emc.2014.04.008","article-title":"Thrombotic microangiopathies (TTP, HUS, HELLP)","volume":"32","author":"Kappler","year":"2014","journal-title":"Emerg. Med. Clin. North Am."},{"key":"10.1016\/j.preghy.2018.02.007_b0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.preghy.2018.02.007_b0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mcna.2016.09.010","article-title":"Syndromes of thrombotic microangiopathy","volume":"101","author":"Shatzel","year":"2017","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.preghy.2018.02.007_b0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review","volume":"166","author":"Abildgaard","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2018.02.007_b0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","article-title":"The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?","volume":"162","author":"Sibai","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0040","first-page":"1122","article-title":"Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","author":"American College of Obstetricians Gynecologists","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0050","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00006250-199011000-00001","article-title":"Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery?","volume":"76","author":"Martin","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0060","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0065","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjh.12718","article-title":"How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome","volume":"164","author":"Scully","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.preghy.2018.02.007_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V50.3.413.413","article-title":"Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura","volume":"50","author":"Bukowski","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2018.02.007_b0075","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2018.02.007_b0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/nep.12935","article-title":"Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab","volume":"22","author":"Chua","year":"2017","journal-title":"Nephrol. (Carlton, Vic)"},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2018.02.007_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nep.12938","article-title":"Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab","volume":"22","author":"Gately","year":"2017","journal-title":"Nephrol. (Carlton, Vic)"},{"key":"10.1016\/j.preghy.2018.02.007_b0090","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/AOG.0000000000001340","article-title":"From gestational hypertension and preeclampsia to atypical hemolytic uremic syndrome","volume":"127","author":"Tsai","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","article-title":"Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome","volume":"175","author":"Audibert","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0889-8545(21)00267-9","article-title":"Imitators of preeclampsia and HELLP syndrome","volume":"18","author":"Martin","year":"1991","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.preghy.2018.02.007_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2015.03.017","article-title":"Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators","volume":"189","author":"Pourrat","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2018.02.007_b0110","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.AOG.0000258281.22296.de","article-title":"Imitators of severe preeclampsia","volume":"109","author":"Sibai","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00041552-199407000-00010","volume":"3","author":"Sibai","year":"1994","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.preghy.2018.02.007_b0120","doi-asserted-by":"crossref","unstructured":"B.B. Feinberg, Preeclampsia: the death of Goliath. American journal of reproductive immunology (New York, NY: 1989) 2006;55:84\u201398.","DOI":"10.1111\/j.1600-0897.2005.00362.x"},{"key":"10.1016\/j.preghy.2018.02.007_b0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMp038241","article-title":"Preeclampsia \u2013 searching for the cause","volume":"350","author":"Solomon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0130","first-page":"137","article-title":"A study of five hundred consecutive cases of pre-eclampsia","volume":"40","author":"Irving","year":"1939","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.preghy.2018.02.007_b0135","first-page":"67","article-title":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists","volume":"77","author":"Practice ACoO","year":"2002","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.preghy.2018.02.007_b0140","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0002-9378(99)70022-0","article-title":"The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification","volume":"180","author":"Martin","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0145","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9378(86)90266-8","article-title":"Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia","volume":"155","author":"Sibai","year":"1986","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14767058.2016.1189897","article-title":"Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?","volume":"30","author":"Haram","year":"2017","journal-title":"J. Maternal Fetal Neonatal Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1479-828X.1993.tb02373.x","article-title":"Standard parameters of preeclampsia: can the clinician depend upon them to reliably identify the patient with the HELLP syndrome?","volume":"33","author":"Magann","year":"1993","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0020-7292(01)00364-2","article-title":"Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders","volume":"73","author":"Vigil-De","year":"2001","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.preghy.2018.02.007_b0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2141.1973.tb05742.x","article-title":"Pregnancy and idiopathic autoimmune haemolytic anaemia: a prospective study during 6 months gestation and 3 months post-partum","volume":"24","author":"Chaplin","year":"1973","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.preghy.2018.02.007_b0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/AOG.0b013e31819388d5","article-title":"Hemolysis and elevated transaminases imitating severe preeclampsia","volume":"113","author":"Kamen","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0180","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2018.02.007_b0185","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0190","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preghy.2018.02.007_b0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.21143","article-title":"ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura","volume":"31","author":"Lotta","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preghy.2018.02.007_b0200","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2013-11-516237","article-title":"How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2018.02.007_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/jth.13189","article-title":"The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies","volume":"14","author":"Phillips","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.preghy.2018.02.007_b0210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.preghy.2018.02.007_b0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jth.13186","article-title":"High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence","volume":"14","author":"von Krogh","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.preghy.2018.02.007_b0220","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1002\/ajh.23997","article-title":"Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center","volume":"90","author":"Benhamou","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.preghy.2018.02.007_b0225","series-title":"UpToDate","article-title":"Acquired TTP: Clinical Manifestations and Diagnosis","author":"James","year":"2017"},{"key":"10.1016\/j.preghy.2018.02.007_b0230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","article-title":"Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network","volume":"175","author":"Ardissino","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.preghy.2018.02.007_b0235","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-3476(05)83531-0","article-title":"Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood","volume":"122","author":"Fitzpatrick","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.preghy.2018.02.007_b0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(96)70361-X","article-title":"Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease","volume":"128","author":"Siegler","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.preghy.2018.02.007_b0245","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.preghy.2018.02.007_b0250","doi-asserted-by":"crossref","first-page":"e0177894","DOI":"10.1371\/journal.pone.0177894","article-title":"Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome","volume":"12","author":"Jamme","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.preghy.2018.02.007_b0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00467-011-2067-7","article-title":"Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective","volume":"27","author":"Kemper","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.preghy.2018.02.007_b0260","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1128\/JCM.00115-15","article-title":"Real-time PCR assay for detection and differentiation of shiga toxin-producing escherichia coli from clinical samples","volume":"53","author":"Qin","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.preghy.2018.02.007_b0265","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00467-016-3420-7","article-title":"Fecal diagnostics in combination with serology: best test to establish STEC-HUS","volume":"31","author":"Wijnsma","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.preghy.2018.02.007_b0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.preghy.2018.02.007_b0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","article-title":"Complement regulatory genes and hemolytic uremic syndromes","volume":"59","author":"Kavanagh","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2006-939770","article-title":"The role of defective complement control in hemolytic uremic syndrome","volume":"32","author":"Zipfel","year":"2006","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.preghy.2018.02.007_b0285","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.bor.0000240370.47336.ae","article-title":"Complement dysfunction in hemolytic uremic syndrome","volume":"18","author":"Zipfel","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.preghy.2018.02.007_b0290","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2018.02.007_b0295","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40620-016-0357-7","article-title":"Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab","volume":"30","author":"Asif","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.preghy.2018.02.007_b0300","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic Uremic Syndrome in Pregnancy and Postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.preghy.2018.02.007_b0305","first-page":"1421","article-title":"Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome","volume":"93","author":"Canigral","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.preghy.2018.02.007_b0310","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1055\/s-0036-1579539","article-title":"Pregnancy-associated atypical hemolytic-uremic syndrome","volume":"6","author":"Saad","year":"2016","journal-title":"AJP Rep."},{"key":"10.1016\/j.preghy.2018.02.007_b0315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-159-1-201307020-00023","article-title":"Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab","volume":"159","author":"Zschiedrich","year":"2013","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0320","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.transci.2011.04.004","article-title":"Early diagnosis and management of postpartum hemolytic uremic syndrome with plasma exchange","volume":"44","author":"Shrivastava","year":"2011","journal-title":"Transfusion Apheresis Sci."},{"key":"10.1016\/j.preghy.2018.02.007_b0325","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/aji.12404","article-title":"Overactivation of complement alternative pathway in postpartum atypical hemolytic uremic syndrome patients with renal involvement","volume":"74","author":"Song","year":"2015","journal-title":"Am. J. Reprod. Immunol. (New York, NY: 1989)"},{"key":"10.1016\/j.preghy.2018.02.007_b0330","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/14767058.2011.619603","article-title":"A high LDH to AST ratio helps to differentiate pregnancy-associated thrombotic thrombocytopenic purpura (TTP) from HELLP syndrome","volume":"25","author":"Keiser","year":"2012","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajog.2008.03.011","article-title":"Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955\u20132006","volume":"199","author":"Martin","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0340","unstructured":"J. George, Approach to the patient with suspected TTP, HUS, or other thrombotic microangiopathy (TMA). UpToDate, Leung LLK (Ed), UpToDate, Waltham, MA. (Accessed on December 02, 2017)."},{"key":"10.1016\/j.preghy.2018.02.007_b0345","unstructured":"J. George, Acquired TTP: clinical manifestations and diagnosis. UpToDate, Leung LLK (Ed), UpToDate, Waltham, MA. (Accessed on December 02, 2017)."},{"key":"10.1016\/j.preghy.2018.02.007_b0350","unstructured":"M. Baha, M. Sibai, HELLP syndrome. In: J. Charles, M. Lockwood, D. MHCMKeith, M.D. Lindor (Eds), Up To Date, Waltham, MA. (Accessed on December 02, 2017.)."},{"key":"10.1016\/j.preghy.2018.02.007_b0355","first-page":"533","article-title":"Successful outcome of therapeutic plasma exchange in post-partum haemolytic-uraemic syndrome: a case report","volume":"10","author":"Dixit","year":"2012","journal-title":"Blood Transfus."},{"key":"10.1016\/j.preghy.2018.02.007_b0360","doi-asserted-by":"crossref","first-page":"255","DOI":"10.11604\/pamj.2014.17.255.2940","article-title":"Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy","volume":"17","author":"Mwita","year":"2014","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.preghy.2018.02.007_b0365","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.preghy.2018.02.007_b0370","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10641950701521221","article-title":"Characteristic laboratory changes in pregnancies complicated by HELLP syndrome","volume":"26","author":"Hupuczi","year":"2007","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2018.02.007_b0375","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/0002-9378(91)91429-Z","article-title":"The natural history of HELLP syndrome: patterns of disease progression and regression","volume":"164","author":"Martin","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.02.007_b0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10641955.2016.1218505","article-title":"Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital","volume":"36","author":"Gedik","year":"2017","journal-title":"Hyperten. Pregnancy"},{"key":"10.1016\/j.preghy.2018.02.007_b0385","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.ajem.2016.08.022","article-title":"Postpartum high fever and imitators of HELLP syndrome","volume":"34","author":"Pourrat","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0390","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2018.02.007_b0395","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0400","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0405","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.preghy.2018.02.007_b0410","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2018.02.007_b0415","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJMoa1414838","article-title":"The sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2018.02.007_b0420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917305123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917305123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:50:33Z","timestamp":1761897033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917305123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":84,"alternative-id":["S2210778917305123"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.02.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733084692.793565322","asserted-by":"object"}]},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic microangiopathies of pregnancy: Differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}